| |
| |
|
| Insider
Information: |
Gould Gregory A |
| Relationship: |
Chief Financial Officer |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
690,662 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,088,263 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
690,662 |
|
|
| Total
Value |
$1,088,263 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
China Medical Technologies Inc |
CMEDQ |
CFO/ Treasurer |
2003-07-18 |
0 |
2003-07-18 |
0 |
Premium* |
|
|
Cytodyn Inc |
CYDY |
Director |
2018-11-16 |
19,176 |
|
0 |
Premium* |
|
|
Seracare Life Sciences Inc |
SRLS |
Interim CEO, CFO, Trea... |
2012-04-20 |
0 |
2009-10-01 |
0 |
Premium* |
|
|
AYTU BIOSCIENCE, INC |
AYTU |
Chief Financial Officer |
2017-02-27 |
340,231 |
2016-07-07 |
0 |
Premium* |
|
|
NewAge Inc |
NBEV |
Chief Financial Officer |
2021-07-02 |
331,255 |
2019-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBEV |
NewAge Inc |
Chief Financial Officer |
• – – |
2021-07-02 |
4 |
D |
$2.24 |
$163,766 |
D/D |
(73,110) |
331,255 |
0 |
- |
|
| NBEV |
NewAge Inc |
Chief Financial Officer |
• – – |
2021-01-05 |
4 |
D |
$2.63 |
$69,713 |
D/D |
(26,507) |
404,365 |
0 |
- |
|
| NBEV |
NewAge Inc |
Chief Financial Officer |
• – – |
2020-12-10 |
4 |
D |
$3.16 |
$30,222 |
D/D |
(9,564) |
430,872 |
0 |
- |
|
| NBEV |
NewAge Inc |
Chief Financial Officer |
• – – |
2020-10-22 |
4 |
D |
$2.72 |
$26,014 |
D/D |
(9,564) |
440,436 |
0 |
- |
|
| NBEV |
NewAge Inc |
Chief Financial Officer |
• – – |
2019-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
450,000 |
0 |
- |
|
| NBEV |
NewAge Inc |
CFO |
• – – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
350,000 |
350,000 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Director |
– • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
19,176 |
19,176 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Director |
– • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(19,176) |
0 |
0 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Chief Financial Officer |
• – – |
2017-02-27 |
4 |
OE |
$0.75 |
$50,000 |
D/D |
66,666 |
340,231 |
0 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Chief Financial Officer |
• – – |
2016-11-02 |
4 |
B |
$1.50 |
$99,999 |
D/D |
66,666 |
273,565 |
2.74 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Chief Financial Officer |
• – – |
2016-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
41,899 |
206,899 |
0 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Chief Financial Officer |
• – – |
2016-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
165,000 |
165,000 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Director |
– • – |
2013-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,125 |
19,176 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Director |
– • – |
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
16,051 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Director |
– • – |
2012-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,562 |
13,551 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Director |
– • – |
2012-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,246 |
11,989 |
0 |
- |
|
| CYDY |
Cytodyn Inc |
Director |
– • – |
2012-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,743 |
8,743 |
0 |
- |
|
| SRLS |
Seracare Life Sciences In... |
Interim CEO, CFO, Treas & Sec. |
• – – |
2012-04-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(237,844) |
0 |
0 |
- |
|
| SRLS |
Seracare Life Sciences In... |
Interim CEO, CFO, Treas & Sec. |
• – – |
2012-03-08 |
4 |
D |
$3.97 |
$4,442 |
D/D |
(1,119) |
237,844 |
0 |
- |
|
| SRLS |
Seracare Life Sciences In... |
Interim CEO, CFO, Treas & Sec. |
• – – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,613 |
237,471 |
0 |
- |
|
| SRLS |
Seracare Life Sciences In... |
Interim CEO, CFO, Treas & Sec. |
• – – |
2011-12-08 |
4 |
D |
$2.92 |
$11,575 |
D/D |
(3,964) |
235,858 |
0 |
- |
|
| SRLS |
Seracare Life Sciences In... |
Interim CEO, CFO, Treas & Sec. |
• – – |
2011-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,710 |
239,822 |
0 |
- |
|
| SRLS |
Seracare Life Sciences In... |
Interim CEO, CFO, Treas & Sec. |
• – – |
2011-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
238,112 |
0 |
- |
|
| SRLS |
Seracare Life Sciences In... |
Interim CEO CFO Treas and Sec |
• – – |
2011-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,157 |
188,112 |
0 |
- |
|
| SRLS |
Seracare Life Sciences In... |
Interim CEO, CFO, Treas. & Sec |
• – – |
2011-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
182,955 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
